IRIS
ZAMPINO, Rosa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.942
EU - Europa 4.423
AS - Asia 990
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 9
AF - Africa 6
OC - Oceania 1
Totale 10.383
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.914
IE - Irlanda 1.573
UA - Ucraina 788
GB - Regno Unito 617
CN - Cina 392
IT - Italia 360
DE - Germania 357
SG - Singapore 346
SE - Svezia 247
FI - Finlandia 207
TR - Turchia 182
GR - Grecia 154
FR - Francia 70
KR - Corea 38
BE - Belgio 17
CA - Canada 16
EU - Europa 12
MX - Messico 12
IN - India 9
NL - Olanda 8
RU - Federazione Russa 8
IR - Iran 6
HK - Hong Kong 5
SA - Arabia Saudita 4
AR - Argentina 3
CO - Colombia 3
ES - Italia 3
JP - Giappone 3
BR - Brasile 2
ET - Etiopia 2
LT - Lituania 2
PL - Polonia 2
BW - Botswana 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
LI - Liechtenstein 1
MA - Marocco 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TN - Tunisia 1
VN - Vietnam 1
Totale 10.383
Salva come PNG Salva come JPEG
Città #
Dublin 1.572
Jacksonville 1.197
Chandler 724
Santa Clara 479
Princeton 243
Singapore 219
Roxbury 195
New York 167
Ann Arbor 143
Cambridge 142
Woodbridge 121
Boardman 117
Bremen 110
Wilmington 108
Medford 105
Beijing 59
San Mateo 55
Jinan 54
Ashburn 53
Des Moines 52
Mountain View 50
Nanjing 48
Düsseldorf 45
Shenyang 40
Seoul 38
Norwalk 28
Napoli 27
Caserta 25
Munich 25
Washington 20
Naples 18
Brussels 17
Helsinki 17
Zhengzhou 17
Changsha 16
Houston 15
Lanzhou 14
Marano Di Napoli 14
Ningbo 14
Haikou 12
Taizhou 12
Tianjin 12
Guangzhou 11
Hebei 11
Nanchang 11
Auburn Hills 10
Guadalupe 10
Rome 9
Bari 8
Bologna 8
Hangzhou 8
Istanbul 8
Los Angeles 8
Seattle 8
Venice 8
Volvera 8
Ottawa 7
Athens 6
Dearborn 6
Fairfield 6
Kunming 6
Latisana 6
Changchun 5
Hong Kong 5
Middlebury 5
Taiyuan 5
Toronto 5
Zanjan 5
Elora 4
Groningen 4
Jiaxing 4
Menlo Park 4
Padova 4
Quarto 4
Rossano 4
San Francisco 4
Amsterdam 3
Duncan 3
Hefei 3
Hyderabad 3
Lappeenranta 3
London 3
Milan 3
Moscow 3
Orange 3
Perugia 3
Philadelphia 3
Torino 3
Addis Ababa 2
Atripalda 2
Berlin 2
Boydton 2
Brindisi 2
Carrara 2
Cassina de' Pecchi 2
Elice 2
Florence 2
Frankfurt am Main 2
Malo 2
Marano 2
Totale 6.724
Salva come PNG Salva come JPEG
Nome #
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 93
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms 87
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 87
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 81
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 76
Nocardiosi polmonare in pazienti con trapianto di cuore: casi clinici 76
Ruolo eziologico e patogenetico del virus dell'epatite C (HCV) nella crioglobulinemia mista (CM) in pazienti con epatite cronica (EC). 76
Analisi della regione del core promoter del virus dell’epatite B (HBV) in pazienti guariti da una malattia oncoematologica con infezione cronica da HBV o da HBV-HCV tre anni dopo sieroconversione ad anti-HBe. 73
Chronic HCV Infection is risk of atherosclerosis. Role of HCV and HCV-related steatosis 73
null 71
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 71
PNPLA3 l148M variant as a risk factor for carotid atherosclerosis in chronic epatiti C 68
Chronic HCV infection and neurological and psychiatric disorders: an overview. 67
HCV RNA levels in serum, liver and PBMC of chronic hepatitis C patients: pathological and therapeutic significance. 66
Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B 64
Long term effect of interferon (IFN) treatment of chronic hepatitis B (CHB) in pediatric patients cured of oncologic diseases 64
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 64
Decrease in HDV endemicity in Italy 63
Aspetti clinico terapeutici della crioglobulinemia mista associata all’epatite cronica C: esperienza su un ampia casistica. 63
Esperienza con l'interferone linfoblastoide nelle epatiti croniche virali 63
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 63
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 62
Favourable effect of alpha-interferon treatment in HBeAb/HBV-DNA positive chronic hepatitis B. 62
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 61
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 61
Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B 60
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 60
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon 60
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 60
Disordini immunologici in corso di epatite cronica da HCV: prevalenza significato clinico ed implicazioni terapeutiche. 60
Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B 60
Analisi della regione del core promoter del virus dell’epatite B (HBV) in pazienti guariti da una malattia oncoematologica con infezione cronica da HBV o da HBV-HCV tre anni dopo sieroconversione ad anti-HBe 59
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 59
Le infezioni respiratorie da Branhamella catarrhalis in pazienti sottoposti a trapianto di cuore. 59
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 59
Effects of long-term alfa interferon treatment in 344 patients with chronic hepatitis C: retrospective analysis of dosage and type of interferon used 57
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 57
Polimorfismo di IL28B nei soggetti con infezione cronica da HCV con transaminasi persistentemente normali e nei pazienti con epatite cronica d HCV 57
Favourable effect of alpha-interferon treatment in HBeAb/HBV-DNA positive chronic hepatitis B 57
Infezioni polmonari micotiche e da nocardia nel paziente cardiotrapiantato: caratteristiche cliniche e trattamento 57
Comunicazione orale: Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 57
L'endocardite da Enterococco: nostra esperienza nel periodo 1988-93. 57
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 57
Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission 56
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 56
Effective itraconazole treatment of pulmonary aspergillosis in heart transplant patients 56
Interferon plus lamivudine treatment in young patients with chronic active B and C hepatitis 56
EFFICACIA DEL TRATTAMENTO CON INTERFERONE RICOMBINANTE E LINFOBLASTOIDE IN PAZIENTI CON EPATITE CRONICA DA HCV 56
Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C 55
Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study 55
Mild chronic hepatitis C with steatosis: Which treatment? 55
Chronic hepatitis B infection in pediatric patients cured of oncologic diseases: natural history and effect of interferon treatment 55
Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis 54
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 54
Meningite batterica: epidemiologia e problematiche attuali di terapia. 54
Correlation of serum HBeAg levels and double A1762T/G1764A HBV core promoter mutation with response to interferon in patients with chronic hepatitis B 54
Hepatitis B virus DNA quantitation and detection of core promoter, precore and polymerase mutations in chronic hepatitis B: evaluation and clinical usefulness of three new commercial assays 53
Le infezioni delle basse vie urinarie: eziologia e suscettibilità agli antibiotici. Nostra esperienza negli ultimi 4 anni. 53
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. 53
Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays 52
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 52
SEQUENTIAL ANALYSIS OF HEPATITIS B VIRUS CORE PROMOTER AND PRECORE REGIONS IN CANCER SURVIVOR PATIENTS WITH CHRONIC HEPATITIS B BEFORE, DURING AND AFTER INTERFERON TREATMENT 52
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 52
HCV-related steatosis and risk of atherosclerosis 52
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 52
Comunicazione orale: Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 52
La presenza della variante Q63 del recettore dei cannabinoidi (CB2) si associa ad un più severa epatonecrosi nei pazienti con epatite cronica C. 52
Efficacia del trattamento con interferone ricombinante e linfoblastoide in pazienti con epatite cronica da HCV. 52
Risk factors for carotid atherosclerosis in chronic hepatitis C: no role of the APOC3 variant 52
Treatment of chronic HBV infection in developing countries. 52
Correlates and prognostic value of the first-phase hepatitis C virus RNA kinetics during treatment 51
Hepatitis G virus/GBV-C persistence: absence of hypervariable E2 region and genetic analysis of viral quasispecies in serum and lymphocytes 51
Tm6sf2 e167k variant is associated with severe steatosis in chronic hepatitis c, regardless of pnapl3 polymorphism 51
Aspetti diagnostici di mutanti della regione HBsAg in pazienti immunocompromessi con riattivazione dell’infezione da virus dell’epatite B (HBV). 51
Le infezioni respiratorie da Branhamella catarrhalis in pazienti sottoposti a trapianto di cuore 51
Infezioni respiratorie da Branhamella Catarralis in pazienti sottoposti a trapianto di cuore 51
ESPERIENZA CON L'INTERFERONE LINFOBLASTOIDE NELLE EPATITI CRONICHE VIRALI 51
Intra-familial transmission of hepatitis B virus in Italy: phylogenetic sequence analysis and amino-acid variation of the core gene 50
Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection 50
A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon 50
First-phase HCV-RNA kinetic during antiviral therapy for chronic hepatitis C: clinical and virological correlates and predictive value for treatment outcome 50
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. 50
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 50
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 50
Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients 49
Low HBeAg serum levels correlate with the presence of the double A1762T/G1764A core promoter mutation and a positive response to interferon in patients with chronic hepatitis B virus infection 49
Comparison of dual HBV-HCV versus single HBV or HCV infections in a previous oncologic pediatric population. 49
Colestasi intraepatica in pazienti sottoposti a trapianto di cuore 49
Correlazione tra livelli di HCV-RNA nel siero, nel fegato e nei linfo-monociti del sangue periferico: possibile ruolo predittivo di risposta all'interferone. 49
Virological patterns of HCV patients with failure to interferon-free regimens. 49
Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 48
Comunicazione orale: Correlates and predictive value of early HCV-RNA kinetic during antiviral treatment 48
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: An open-label, randomised controlled trial 48
Correlation between hepatitis C virus RNA levels in serum, liver, peripheral blood mononuclear cells and severity of liver disease in chronic hepatitis C patients. apitolo 27, pag. 244-250, 1996. 47
Le infezioni batteriche nel paziente con trapianto di cuore. 47
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. 47
Hepatic steatosis and necro-inflammatory activity overestimated liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C 47
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosi 47
Long-term outcome of HBV-HCV co-infection and HBV mono-infection acquired in youth 46
Le infezioni delle basse vie urinarie: eziologia e suscettibilità agli antibiotici.Nostra esperienza negli ultimi 4 anni. 46
Totale 5.726
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.138
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.138
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020625 0 0 0 0 202 24 245 34 53 22 38 7
2020/20211.780 128 4 192 105 412 7 227 183 13 233 202 74
2021/20221.446 58 13 4 14 482 19 26 44 63 149 110 464
2022/20232.945 261 50 33 228 339 227 10 168 1.486 25 56 62
2023/20241.182 94 28 41 72 421 181 34 36 6 13 88 168
2024/2025737 8 48 33 87 561 0 0 0 0 0 0 0
Totale 10.817